These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 34996736)
21. mTOR signaling intervention by Torin1 and XL388 in the insular cortex alleviates neuropathic pain. Choi S; Kim K; Cha M; Kim M; Lee BH Neurosci Lett; 2020 Jan; 718():134742. PubMed ID: 31917234 [TBL] [Abstract][Full Text] [Related]
22. Growing knowledge of the mTOR signaling network. Huang K; Fingar DC Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279 [TBL] [Abstract][Full Text] [Related]
23. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. Feldman ME; Apsel B; Uotila A; Loewith R; Knight ZA; Ruggero D; Shokat KM PLoS Biol; 2009 Feb; 7(2):e38. PubMed ID: 19209957 [TBL] [Abstract][Full Text] [Related]
24. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis. Mi W; Ye Q; Liu S; She QB Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827 [TBL] [Abstract][Full Text] [Related]
25. Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implications. Montero JC; Chen X; Ocaña A; Pandiella A Mol Cancer Ther; 2012 Jun; 11(6):1342-52. PubMed ID: 22496482 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction. Kakiuchi Y; Yurube T; Kakutani K; Takada T; Ito M; Takeoka Y; Kanda Y; Miyazaki S; Kuroda R; Nishida K Osteoarthritis Cartilage; 2019 Jun; 27(6):965-976. PubMed ID: 30716534 [TBL] [Abstract][Full Text] [Related]
27. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Wang B; Jie Z; Joo D; Ordureau A; Liu P; Gan W; Guo J; Zhang J; North BJ; Dai X; Cheng X; Bian X; Zhang L; Harper JW; Sun SC; Wei W Nature; 2017 May; 545(7654):365-369. PubMed ID: 28489822 [TBL] [Abstract][Full Text] [Related]
28. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin. Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676 [TBL] [Abstract][Full Text] [Related]
29. mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and Tavares C; Eloy C; Melo M; Gaspar da Rocha A; Pestana A; Batista R; Bueno Ferreira L; Rios E; Sobrinho Simões M; Soares P Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757257 [TBL] [Abstract][Full Text] [Related]
30. Inhibiting 4EBP1 in Glioblastoma. Fan QW; Nicolaides TP; Weiss WA Clin Cancer Res; 2018 Jan; 24(1):14-21. PubMed ID: 28696243 [TBL] [Abstract][Full Text] [Related]
31. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058 [TBL] [Abstract][Full Text] [Related]
32. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1. Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665 [TBL] [Abstract][Full Text] [Related]
33. PI3K/mTOR signaling regulates prostatic branching morphogenesis. Ghosh S; Lau H; Simons BW; Powell JD; Meyers DJ; De Marzo AM; Berman DM; Lotan TL Dev Biol; 2011 Dec; 360(2):329-42. PubMed ID: 22015718 [TBL] [Abstract][Full Text] [Related]
34. Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment. Heinzen D; Divé I; Lorenz NI; Luger AL; Steinbach JP; Ronellenfitsch MW Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510109 [TBL] [Abstract][Full Text] [Related]
35. Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors. Melick CH; Jewell JL Biochem J; 2020 May; 477(10):1847-1863. PubMed ID: 32347294 [TBL] [Abstract][Full Text] [Related]
36. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis. Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809 [TBL] [Abstract][Full Text] [Related]
37. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
38. Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin. Watanabe T; Sato A; Kobayashi-Watanabe N; Sueoka-Aragane N; Kimura S; Sueoka E Anticancer Res; 2016 Jan; 36(1):95-102. PubMed ID: 26722032 [TBL] [Abstract][Full Text] [Related]